The antibacterial, antifungal and antitubercular activity of Cu(II) complexes was studied. All the complexes have been screened against Staphylococcus aureus, Salmonella typhi, Candida albican, Aspergillus niger, Saccharomyces cerevisiae and H37Rv and found to be more toxic than the parent ligand. The activity increased in the order Cu(5-methyl-2,3-hexanedione dioxime)2 < Cu(5-methyl-3-oximino-hexan-2-o-ne-hydrazone)2 < Cu(5-methyl-3-oximino-hexan-2-one-phenylhydrazone)2.